Global Continence
Atlanta, US · Founded 2021 · Delaware corporation
Global Continence Inc. develops Soluu, a wearable non-invasive neuromodulation device to help children with bedwetting (nocturnal enuresis) recognize bladder fullness and improve nighttime dryness, and publishes an educational guide for parents. The device is investigational and under FDA review, not yet available for sale.
Founders & leadership
AJ
Andrew J. KirschChief Executive Officer
Board
AK
Andrew KirschPediatric Urologist
UB
Ubirajara BarrosoPediatric Urologist
Reported raises · per SEC filings
Form D private placements$835K disclosed across 1 round · 2021
▶$835KraisedSep 2022 · 37 investors · Other Health CareRule 506(b)
▶$835KraisedSep 2022 · 37 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Andrew J. KirschExecutive Officer
- Offering amount
- $835K
- Amount sold
- $835K
- Minimum investment
- $10K
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Global Continence do?
- Global Continence Inc. develops Soluu, a wearable non-invasive neuromodulation device to help children with bedwetting (nocturnal enuresis) recognize bladder fullness and improve nighttime dryness, and publishes an educational guide for parents. The device is investigational and under FDA review, not yet available for sale.
- How much funding has Global Continence raised?
- Global Continence has disclosed $835K raised across 1 round.
- Where is Global Continence headquartered?
- Global Continence is headquartered in Atlanta, US.